Figure 2
Change in type of AF from baseline to 1 year. Red arrows and numbers represent patients with AF progression and grey arrows and numbers represent patients without AF progression. aIncrease in AF burden was defined according to the AF progression definition: a doubling in AF burden at one year with at least an AF burden of 10%. bAll patients with persistent AF underwent a cardioversion at baseline. AF, atrial fibrillation; LA, left atrium; NT-proBNP, N-terminal pro-B-type natriuretic peptide; PAI-1, plasminogen activator inhibitor.

Change in type of AF from baseline to 1 year. Red arrows and numbers represent patients with AF progression and grey arrows and numbers represent patients without AF progression. aIncrease in AF burden was defined according to the AF progression definition: a doubling in AF burden at one year with at least an AF burden of 10%. bAll patients with persistent AF underwent a cardioversion at baseline. AF, atrial fibrillation; LA, left atrium; NT-proBNP, N-terminal pro-B-type natriuretic peptide; PAI-1, plasminogen activator inhibitor.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close